Small Cap Feast

Small Cap Feast – 30 April 2019

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 897

Total number of AIM Companies trading: 826*
* As at 25 April 2019

Set Menu NEX Growth:

Total number of NEX Growth Market Companies (Incl Susp): 89*

Total number of NEX Growth Market Companies trading: 87*
* As at 25 April 2019

Set Menu Standard List:

Total number of Standard List Companies (Incl Susp): 161*

Total number of Standard List Companies trading: 141*
* As at 25 April 2019

Dish of the Day:

No Joiners Today

Off the Menu:

No Leavers Today

Dish of the Day:

No Joiners Today

Off the Menu:

No Leavers Today

What’s Cooking in the IPO Kitchen?

Main Market

Finablr plc— global platform which provides Cross-Border Payments and Consumer Solutions, Consumer Foreign Exchange Solutions and B2B and Payment Technology Solutions to consumers and businesses in the large and growing payments and foreign exchange market is looking to list on the Main Market plans to raise $200m, expected 1 May 2019

Main Market (Standard)

IMC Exploration Group (NEX: IMCP), focused on acquiring and exploring prospecting licence areas which have high potential for natural resource, is looking to admit its shares to the standard list and will withdraw for the NEX Exchange. Expected 11 June 2019

AIM

Techniplas –global  producer and support services company providing highly engineered and technically complex components, making the supply chain to original equipment manufacturers more efficient.  FYDec17 rev $515m.

SDX Energy plc—a North Africa focused oil and gas company, announces its intention to complete a Canadian plan of arrangement under section 192 of the Canada Business Corporations Act and will have shares de-listed from the TSX-V and admitted to trading on AIM. Expected 28 May 2019, anticipated market cap of £76m

Renold plc—a leading international supplier of industrial chains and related power transmission products, announced that it will cancel the listing of the Company from the premium segment and apply for admission on AIM. Expected 06 June 2019.

Distribution Finance Capital Holdings plc — specialist lender which builds relationships with manufacturers and then provides working capital solutions up and down their supply chains to drive their growth is looking to join AIM. No raise, secondary offering of £19.8m at 90p, expected market cap of £95.98m. Expected 09 May 2019.

Alumasc Group plc, the premium building products, systems and solutions group, has announced its intention to move from the Premium Segment of the main market to AIM. Expected 25 June 2019

Breakfast Buffet

LMS Capital (LMS.L) 50.4p £40.69m

LMS Capital plc issued the following update covering the period from 1 Jan 2019 to date.

The Company’s unaudited NAV at 31 March 2019 was £59.6m (31 Dec 2018 £60.3m), equivalent to 73.8p per share (31 Dec 2018: 74.7p per share). The most significant movements in net asset value during the quarter were:

The investment portfolio showed net gains of £0.3m, excluding the impact of exchange rate movements. The principal items were an increase of £0.6m in the value of the shares in Gresham House and a reduction of £0.5m in the valuation of YesTo;

Strengthening of sterling against the US Dollar in the period to 31 March 2019 has resulted in an unrealised exchange loss of £0.6m;

Other net changes amount to a £0.4m reduction, the main item of which is overhead costs.

There was no material change in the cash balance during the quarter. Continued progress is being made with the realisation of one of the company’s unquoted investments, which could result in further proceeds being received.

 

Gooch & Housego (GHH.L) 1,527p £381.2m

Gooch & Housego, the specialist manufacturer of optical components and systems, announced that Chris Jewell will be appointed to the Board of Directors as CFO  from Oct 2019 at the latest.

Chris has extensive executive and financial experience, with a successful track record in technology led, global engineering and manufacturing businesses operating in A&D, Industrial and Life Science markets.

He is currently Group Director of Financial Control at TT Electronics PLC and has previously held senior finance positions at Cobham PLC and MBDA UK.

Chris is a Fellow of the Institute of Chartered Accountants, holds a first class honours degree in History from Cambridge University and an MA from the London School of Economics.

Andy Boteler, our current CFO, will step down from the Board of Directors in June 2019 and in the interim period before Chris’ start date, our Group Financial Controller Gareth Crowe will lead our finance function.

 

Dillistone Group (DSG.L) 43p £8.06m

Dillistone Group, the supplier of recruitment software for the international recruitment industry through its Dillistone Systems, Voyager Software and GatedTalent divisions, to announced its audited final results for the 12 months ended 31 Dec 2018.

Recurring revenues represent 82% (restated 2017: 82%) of Group revenue

Adjusted operating profit2 of £0.055m (restated 2017: £0.459m) before acquisition intangible writes offs, reflecting the loss of the major contract announced in 2017 which reduced revenues by £0.625m compared to 2017 in a ten-month period

Loss for the year of £0.260m (restated 2017: profit £0.057m)

Adjusted basic EPS3 of 0.61p (2017: 3.73p)

The Group continued to generate cash from operating activities resulting in cash at 31 December 2018 of £0.725m (2017: £1.390m) with borrowings of £0.404m (2017: £0.391m).

 

Wilmcote Holdings (WCH.L) 97.5p £20.3m

Wilmcote Holdings announced the appointment of Kevin Dangerfield as CFO and a Director of the Company effective from 1 July 2019.

Kevin joins Wilmcote from Laird, the leading UK electronic components maker, where he has been CFO since Oct 2016, continuing in the role since Laird’s acquisition by Advent International in 2018.

During his tenure at Laird, Kevin successfully led the group through a re-organisation and strategic re-focus, significantly improving margins and cash flow, and subsequently negotiating the sale to Advent.

Prior to Laird, Kevin served as CFO of Morgan Advanced Materials plc from 2006 to 2016, following six years as Group Financial Controller (2000-2006).

Adrian Whitfield, Wilmcote’s Chief Executive Officer commented: “I am delighted to welcome Kevin to Wilmcote. He has extensive knowledge and experience that will support the successful delivery of our investment strategy”.

 

Anglo African Oil & Gas (AAOG) 10.4p £23.79m

Anglo African Oil & Gas, an independent oil and gas developer, announced the receipt of a letter from the Government of the Republic of the Congo signed by the Minister of Hydrocarbons,  Monsieur Jean-Marc Thystere Tchicaya, formally offering a new licence to Petro Kouiliou, the Company’s wholly owned subsidiary, over the producing Tilapia oil field.  The Company and the Government will now work together to finalise the terms of a new Production Sharing Contract for the new Tilapia licence.

Importantly, the Company has been informed through the letter that the New Licence will have a 25-year period and that PK will retain its current 56% interest in Tilapia.

 

Sareum Holdings* (SAR.L) 0.72p £20.85m

Sareum Holdings, the specialist small molecule drug development business, announces that its CEO, Dr Tim Mitchell, will give a company presentation at BioTrinity 2019 in London, which takes place from 30 April – 1 May.

The presentation, to be held today at 11:05am BST, will introduce Sareum and provide an overview of its lead programmes, including SRA737, a novel Chk1 inhibitor licensed to Sierra Oncology (NASDAQ: SRRA) and its two TYK2/JAK1 kinase programmes, SDC-1801 and SDC-1802, targeting autoimmune diseases and cancers.

 

Rosenblatt Group (RBGP.L) 100p £79.29m

Rosenblatt Group, the professional legal services company, announced its audited preliminary results for the period ended 31 Dec 2018.

Revenue of £12.5m, up 19% (2017: £10.5m)

Adjusted EBITDA of £4.3m, up 18% (2017: £3.6m),

Profit before tax of £3m (2017: £3.2m)

Profit after tax of £2.3m, representing 18.4% of revenue

Strong balance sheet with net assets of £35m and no debt

Cash and cash equivalents of £13.4m

First interim dividend for the eight months to 31 Dec 2018 of 2.8p per share will be paid to shareholders on the register as at 10 May 2019

 

Animalcare (ANCR.L) 145.5p £84.98m

Animalcare Group, the European Animal Health business, announced its full year results for the year ended 31 Dec 2018.

Reported revenue growth of 16.3% to £72.5m (2017: £62.3m). Up 2.7% on a proforma basis

Underlying EBITDA increased by 21.7% to £11.8m. Up 2.8% on a proforma basis

Statutory loss before tax, which incorporates non-underlying items, decreased to £0.4m (2017: £0.4m profit) with reported basic loss per share decreased to 1.7p (2017: 0.2p earnings per share)

Improved underlying cash conversion to 79.9% (2017: 65.9%) with net debt reduced by £2.3m to £23.6m

Proposed final dividend of 2.4 pence per share giving a total dividend of 4.4 pence per share for 2018

 

Staffline (STAFF.L) 882p £246.4m

Staffline provided the following update regarding the publication of its final results for the year ended 31 Dec 2018.

As set out in the Company’s announcement on 30 March 2019, following allegations by a third party in respect of invoicing and payroll practices within the Group’s Recruitment division, a review was instigated including the appointment of independent legal advisers as well as instructing the Group’s auditors to extend their scope of work.

The independent legal report has now been delivered in full and there are no further matters to report beyond those in the key findings interim report, which were described in the announcement of 30 March 2019. Significant progress has been made on the extended audit and the Board continues to expect to report, subject to audit completion, an underlying trading performance for the year ended 31 December 2018 in line with expectations.

The key outstanding matter in finalising the results relates to the Group’s historical compliance with National Minimum Wage Regulations 2015. This is a complex area and management, in conjunction with HMRC and supported by an independent advisor, are assessing the significant amount of historic data and transactions, which will then be subject to audit. Once the work is completed and audited, Staffline will release its preliminary results and shareholders will be updated as appropriate.

 

Thor Mining (THR.L) 0.68p £5.51m

The Board of Thor Mining announced positive interim results from drilling at the Bonya tungsten deposits, adjacent Molyhil, in the Northern Territory of Australia.

The Bonya project is held in joint venture with Arafura Resources Limited (ASX: “ARU”), with both parties contributing to the cost of the program in proportion to their project equity (THR 40% : ARU 60%).

Interim results for three of the four targets are now available following portable x-ray fluorescence (“XRF”) determination, and should be considered preliminary and subject to confirmation in subsequent laboratory assay.  Laboratory assays results may vary from those obtained from XRF.

27 metres @ 0.32% WO₃ from 71 metres, and 16 metres @ 0.43% Copper from 43 metres, from White Violet hole 19RC020 ;

12 metres @ 0.70% WO₃ from 35 metres and 25 metres @ 0.42% WO₃ from 63 metres from White Violet hole 19RC021;

29 metres @ 0.75% WO₃ from 81 metres, including 13 metres @ 1.43% WO₃ from 91 metres from White Violet hole 19RC022;

2 metres @ 0.43% WO₃ from 16 metres from Tashkent hole 19RC001;

2 metres @ 0.52% WO₃ from 31 metres from Jericho hole 19RC008.

 

Head Chef:

Derren Nathan
0203 764 2344
derren.nathan@hybridan.com

*A corporate client of Hybridan LLP

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.